AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants

Investigational drug excels in preclinical models

2013-04-09

(Press-News.org) The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.

"With molecularly targeted agents, we typically see 3 or 4 CRC explant models with a significant decrease in tumor growth. Here we have a drug that was active in every explant we tested. It's really exciting," says John Arcaroli, PhD, investigator at the University of Colorado Cancer Center and assistant professor in the Division of Medical Oncology at the University of Colorado School of Medicine, the study's senior author. Dr. Arcaroli works with Wells Messersmith, MD, co-leader of the CU Cancer Center Developmental Therapeutics Program to develop and test novel compounds for the treatment of gastrointestinal malignancies.

This drug appears to work by inhibiting angiogenesis – the growth of new blood vessels that tumor tissues need to supply themselves with nutrients. Unlike other drugs that target angiogenesis, XL-184 targets not only the primary driver of angiogenesis, the VEGFR2 signaling pathway, but also targets c-Met, a pathway that is important for survival of tumor cells.

"Other studies have shown that anti-VEGF therapy decreases angiogenesis, but also promotes tumor cell survival and metastasis that is dependent on the c-MET signaling pathway," Arcaroli says. "This drug inhibits both – the formation of blood vessels and a primary escape mechanism whereby tumor cells survive. This two-target approach may be the reason we're seeing very potent effects with this agent."

The group, which also includes members from the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center and from Harvard Medical School, is now investigating the mechanisms by which the compound reduces tumor growth. The group also plans additional explant testing in order to identify predictive biomarkers of sensitivity or resistance to XL-184. In combination, this work will likely lead to a Phase II biomarker-driven clinical trial of the drug in patients with metastatic colorectal cancer. ### END

ELSE PRESS RELEASES FROM THIS DATE:

AACR news: Autophagy-addicted breast cancers killed by anti-malaria drug, chloroquine

2013-04-09

The process of autophagy cleans cells – they wrap up the bad stuff and then dispose of it. And so it stands to reason that inhibiting autophagy would make cancer cells less able to cleanse themselves of chemotherapy and so more susceptible to the drugs. That's what the traditional anti-malaria drug, chloroquine, does – it inhibits autophagy. Existing clinical trials are testing chloroquine/chemotherapy combinations against breast cancer. Research presented at the AACR Annual Meeting 2013 shows that some breast cancer subtypes depend on autophagy more than others – and ...

Possible predictive biomarker for patients who may respond to autophagy inhibitors

2013-04-09

WASHINGTON, DC – Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation. Using drugs to shut down that survival mechanism shows great promise, especially when combined with targeted agents and standard chemotherapies, but until recently, it has been unclear which patients' cancers would respond to that combination therapy. A team led by researchers from the ...

Surface diffusion plays a key role in defining the shapes of catalytic nanoparticles

2013-04-09

Controlling the shapes of nanometer-sized catalytic and electrocatalytic particles made from noble metals such as platinum and palladium may be more complicated than previously thought. Using systematic experiments, researchers have investigated how surface diffusion – a process in which atoms move from one site to another on nanoscale surfaces – affects the final shape of the particles. The issue is important for a wide range of applications that use specific shapes to optimize the activity and selectivity of nanoparticles, including catalytic converters, fuel cell ...

Thinking you're old and frail

2013-04-09

Older adults who categorise themselves as old and frail encourage attitudinal and behavioural confirmation of that identity. This is the conclusion of a study conducted by Krystal Warmoth and colleagues at University of Exeter Medical School, which is being presented today, 9th April 2013, at the British Psychological Society Annual Conference in Harrogate, UK. Krystal Warmoth interviewed 29 older adults in the South West of England face-to-face. Interviews conducted asked about their experiences of ageing and frailty. Self-perception and identification related to ...

Particles changing angle: Unexpected orientation in capillaries

2013-04-09

When small particles flow through thin capillaries, they display an unusual orientation behaviour. This has recently been discovered by a research team led by Prof. Stephan Förster and Prof. Walter Zimmermann (University of Bayreuth, Germany) at the X-ray sources DORIS III and PETRA III of the research centre DESY in Hamburg, Germany. The discovery is of major importance for spinning processes designed for the production of synthetic fibres, and for the understanding of vascular stenosis. The scientists of Bayreuth University, the Radboud University Nijmegen (Netherlands), ...

Moving cells with light holds medical promise

2013-04-09

Scientists at Washington University School of Medicine in St. Louis have shown they can coax cells to move toward a beam of light. The feat is a first step toward manipulating cells to control insulin secretion or heart rate using light. Their research is published April 8 in the Proceedings of the National Academy of Sciences Online Early Edition. "We have succeeded in using light as a kind of on-off switch to control cells' behavior," says principal investigator N. Gautam, PhD, a professor of anesthesiology. "Much of the way cells behave is due to their ability to ...

University of Tennessee professor's research shows Gulf of Mexico resilient after spill

2013-04-09

The Gulf of Mexico may have a much greater natural ability to self-clean oil spills than previously believed, according to Terry Hazen, University of Tennessee-Oak Ridge National Laboratory Governor's Chair for Environmental Biotechnology. The bioremediation expert presented his Deepwater Horizon disaster research findings at the 245th National Meeting and Exposition of the American Chemical Society (ACS), the world's largest scientific society. Hazen conducted research following the 2010 Deepwater Horizon disaster, which is estimated to have spilled 210 million gallons ...

A hijacking of healthy cellular circuits

2013-04-09

April 8, 2013, New York, NY and San Diego Calif. – Proteins that control cell growth are often mutated in cancer, and their aberrant signaling drives the wild proliferation of cells that gives rise to tumors. One such protein, the epidermal growth factor receptor (EGFR), fuels a wide variety of cancers—including a highly malignant brain cancer known as glioblastoma. Yet drugs devised to block its signaling tend to work only for a short while, until the cancer cells adapt to evade the therapy. So far, much of the research examining such drug resistance has focused on how ...

A fly mutation suggests a new route for tackling ALS

2013-04-09

WASHINGTON, D.C. – April 8, 2013— A team of researchers, led by Marc Freeman, PhD, an early career scientist with the Howard Hughes Medical Institute and associate professor of neurobiology at the University of Massachusetts Medical School have discovered a gene in the fruit fly Drosophila melanogaster that, when mutant, blocks the self-destruction of damaged axons, which could hold clues to treating motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). A neuron has a very distinctive form – a bush of dendrites that receive signals, an incredibly long axon, ...

Marriages benefit when fathers share household, parenting responsibilities, MU researcher says

2013-04-09

COLUMBIA, Mo. – Although no exact formula for marital bliss exists, a University of Missouri researcher has found that husbands and wives are happier when they share household and child-rearing responsibilities. However, sharing responsibilities doesn't necessarily mean couples divide chores equally, said Adam Galovan, a doctoral student in the MU Department of Human Development and Family Studies. "Sharing can mean something different to every couple," Galovan said. "It could be taking turns changing diapers or one parent watching the children while the other prepares ...

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals

Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award

[Press-News.org] AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
Investigational drug excels in preclinical models

AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: